Key statistics
On Tuesday, Passage Bio Inc (PASG:NSQ) closed at 0.6122, 7.20% above its 52-week low of 0.5711, set on Oct 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.6062 |
---|---|
High | 0.656 |
Low | 0.590 |
Bid | 0.6428 |
Offer | 0.67 |
Previous close | 0.601 |
Average volume | 242.16k |
---|---|
Shares outstanding | 61.77m |
Free float | 61.47m |
P/E (TTM) | -- |
Market cap | 37.12m USD |
EPS (TTM) | -1.36 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference
- Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)
- Passage Bio Welcomes Tom Kassberg to Board of Directors
- Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
- Passage Bio to Participate in Upcoming Investor Conferences
- Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration
- Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
- Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
- Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
More ▼